| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.15 | 0.01 |